Sat, Dec 20, 2014, 2:20 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Spectrum Pharmaceuticals, Inc. Message Board

  • dcaf7 dcaf7 Jan 28, 2013 8:21 PM Flag

    Belinostat in NSCLC

    is where real money could be made. Spectrum conducts phase 2 trial "Maximum Tolerated Dose Study of Belinostat (PXD-101)in Combination With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Stage IV Non-Small-Cell Lung Cancer (NSCLC)" which has a primary completion date as December 2012. Guess they already know the results.

7.17-0.07(-0.97%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.